AGTC to Showcase Interim Findings from Ongoing XLRP and

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical...

Related Keywords

Colorado ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Oregon ,Denver ,Jonathan Lieber ,Rachel Huckfeldt ,Paul Yang ,Kerry Sinclair ,Susan Schneider ,Alessandro Iannaccone ,Genetic Technologies Corporation ,Professor Of Ophthalmology At Harvard Medical School ,Spectrum Science Communications ,Otonomy Inc ,Nasdaq ,Casey Eye Institute ,Oregon Health Science University In Portland ,Association For Research ,Chief Medical Officer ,Visual Photosensitivity ,Two Phase ,Subretinal Gene Therapy ,Assistant Professor ,Harvard Medical School ,Four Seasons Ballroom ,Safety Results ,Dose Escalation Clinical Trials ,Retinal Degenerations ,Ophthalmic Genetic Diseases ,Duke University School ,Month Analysis ,Subretinal Gene Therapy Drug ,X Linked Retinitis Pigmentosa ,Oregon Health ,Science University ,Bionic Sight ,Looking Statements ,Nasdaq Agtc ,Applied Genetic Technologies Corporation ,